Related Experiment Video
Updated: Aug 13, 2026

Using Real-Time Cell Metabolic Flux Analyzer to Monitor Osteoblast Bioenergetics
Published on: March 1, 2022
[Bone remodeling and mineral homeostasis]
Midori Nakamura1, Nobuyuki Udagawa, Hiroshi Nakamura
1Department of Biochemistry, Matsumoto Dental University.
Abstract:
The discovery of receptor activator of nuclear factor-kappaB ligand (RANKL) elucidates the mechanism of osteoclast differentiation and function regulated by osteoblasts. Osteoprotegerin (OPG), a soluble decoy receptor of RANKL, inhibits both differentiation and function of osteoclasts. OPG-deficient (OPG-/-) mice exhibited severe osteoporosis caused by enhanced osteoclastic bone resorption. Deficiency of OPG in human has been shown to result in juvenile Paget's disease. Blood alkaline phosphatase activity of OPG-/- mice was about four times as high as that of wild-type mice. These results suggest that osteoclastic bone resorption coincidentally induces osteoblastic bone formation by an unknown factor (called coupling factor). Collagen sponge disks containing bone morphogenetic protein-2 (rhBMP-2) were implanted into the dorsal muscle pouches in OPG-/- mice and wild-type mice, and bone mineral density (BMD) of the collagen sponge disks was determined every week for 3 weeks. No significant difference in BMD of the disc was observed between OPG-/- mice and wild-type mice. These results suggest that bone formation is accurately coupled with bone resorption at local sites in OPG-/- mice.
Insights
Osteoprotegerin (OPG) deficiency causes severe osteoporosis due to increased bone resorption. However, bone formation remains coupled with resorption locally, even without OPG.
Area of Science:
- Biochemistry
- Orthopedics
- Cell Biology
Background:
- Receptor activator of nuclear factor-kappaB ligand (RANKL) regulates osteoclast activity.
- Osteoprotegerin (OPG) inhibits osteoclast differentiation and function.
- OPG deficiency leads to severe osteoporosis and elevated alkaline phosphatase.
Purpose of the Study:
- To investigate the relationship between osteoclast-mediated bone resorption and osteoblast-mediated bone formation in OPG-deficient mice.
- To determine if bone formation is coupled with resorption at local sites in the absence of OPG.
Main Methods:
- Utilized OPG-deficient (OPG-/-) mice and wild-type littermates.
- Implanted collagen sponge disks with bone morphogenetic protein-2 (rhBMP-2) into dorsal muscle pouches.
- Measured bone mineral density (BMD) of the implants over three weeks.
Main Results:
- OPG-/- mice exhibited severe osteoporosis with enhanced osteoclastic bone resorption.
- No significant difference in BMD development was observed between OPG-/- and wild-type mice in the implanted disks.
- Blood alkaline phosphatase activity was significantly higher in OPG-/- mice.
Conclusions:
- Despite severe osteoporosis and enhanced bone resorption, bone formation is accurately coupled with bone resorption at local sites in OPG-/- mice.
- These findings suggest a localized coupling mechanism independent of systemic OPG levels.
Related Concept Videos
Bone Remodeling
Osteoclasts in Bone Remodeling
Bone Remodeling and Repair
Skeleton and Calcium Homeostasis
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
The Bone Matrix
